BioMarin Pharmaceutical Inc.
776 articles with BioMarin Pharmaceutical Inc.
-
BioMarin Pharmaceutical Inc. And Serono, Inc. Announce Positive Results From Phase 3 Clinical Study Of Phenoptin For PKU; Shares Up
3/16/2006
-
BioMarin Pharmaceutical Inc. And ALLIANT Pharmaceuticals, Inc. Announce North American Licensing Agreement For Orapred
3/16/2006
-
BioMarin Pharmaceutical Inc. To Present At SG Cowen & Co., LLC 26th Annual Health Care Conference
2/28/2006
-
BioMarin Pharmaceutical Inc. Announces Fourth Quarter And Year-End 2005 Financial Results
2/24/2006
-
BioMarin Pharmaceutical Inc. to Host Fourth Quarter And Year-End 2005 Earnings Call And Webcast On Thursday, February 23 At 5:00 P.M. ET (23:00 CET)
2/22/2006
-
BioMarin Pharmaceutical Inc. Receives Marketing Approval For Naglazyme In European Union
1/31/2006
-
BioMarin Pharmaceutical Inc. Receives FDA Fast Track Designation For Phenoptin For PKU
1/26/2006
-
BioMarin Pharmaceutical Inc. Establishes Commercial Operations In Europe
1/11/2006
-
BioMarin Pharmaceutical Inc. To Host Research And Development Day On Tuesday, December 6
11/22/2005
-
BioMarin Pharmaceutical Inc. To Present At The SG Cowen & Co., LLC 6th Annual Global Health Care Conference
11/4/2005
-
BioMarin Pharmaceutical Inc. Announces Third Quarter 2005 Financial Results
11/2/2005
-
BioMarin Pharmaceutical Inc. To Present At The Rodman And Renshaw Techvest 7th Annual Healthcare Conference
11/1/2005
-
BioMarin Pharmaceutical Inc. Announces U.S. FDA Acceptance Of Orapred ODT Filing
10/20/2005
-
WeissComm Partners Adds Four New Clients
10/12/2005
-
BioMarin Pharmaceutical Inc. Follows Genzyme Corporation's Playbook
8/23/2005
-
The Day In Review: Biotech Takes First Loss In A Week
5/5/2005